We are live on
!
Find out more
TCM
Tenor Capital Management Portfolio holdings
AUM
$6.49B
1-Year Est. Return
3.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.13%
1 Year Est. Return
+3.01%
3 Year Est. Return
+3.92%
5 Year Est. Return
+4.42%
10 Year Est. Return
+12.15%
AUM
$711M
AUM Growth
+$300M
(+73%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-43.49%
Top 10 Holdings %
Top 10 Hldgs %
68.76%
Holding
43
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TMBR
Timber Pharmaceuticals, Inc.
TMBR
|
+$21.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 0.29% |
| 2 | Technology | 0.17% |
| 3 | Healthcare | 0.01% |
Similar funds
HI
CG
BF
BFS
LAM
OCM
HFS
PCH
Tenor Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Tenor Capital Management held 43 positions worth $711M, up 73% from $411M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Tenor Capital Management withdrew a net $309M in Q3 2016, reducing 1 holding. Its largest reduction was Timber Pharmaceuticals, Inc., cutting an estimated $21.1K.
By sector, the portfolio is most concentrated in Communication Services at 0.29% of assets, down from 0.38% a quarter earlier, followed by Technology and Healthcare.
- Tenor Capital Management's biggest Q3 2016 reduction was Timber Pharmaceuticals, Inc., cutting an estimated $21.1K.
- Tenor Capital Management's ten largest holdings make up 69% of its $711M portfolio in Q3 2016.
- Tenor Capital Management opened 0 new positions and closed 0 in Q3 2016.
- Tenor Capital Management's portfolio value rose 73% quarter-over-quarter to $711M.
Based on Tenor Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.